This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05502237
Brief Title: Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer (STAR-121)

First Submitted : August 12, 2022
First Submitted that Met QC Criteria : August 12, 2022
First Posted : August 16, 2022

Last Update Submitted that Met QC Criteria : April 5, 2024
Last Update Posted : April 8, 2024